Electroacupuncture-Induced Cholinergic Nerve Activation Enhances the Hypoglycemic Effect of Exogenous Insulin in a Rat Model of Streptozotocin-Induced Diabetes

被引:18
|
作者
Lee, Yu-Chen [1 ,2 ]
Li, Te-Mao [1 ]
Tzeng, Chung-Yuh [3 ,4 ]
Cheng, Yu-Wen [3 ,5 ]
Chen, Ying-I [6 ,7 ]
Ho, Wai-Jane [6 ]
Lin, Jaung Geng [1 ]
Chang, Shih-Liang [1 ,6 ]
机构
[1] China Med Univ, Sch Chinese Med, Taichung, Taiwan
[2] China Med Univ Hosp, Dept Acupuncture, Taichung, Taiwan
[3] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan
[4] Taichung Vet Gen Hosp, Dept Orthoped, Taichung, Taiwan
[5] Lees Gen Hosp, Dept Internal Med, Miaoli, Taiwan
[6] Da Yeh Univ, Dept Med Bot & Hlth Care, Chunghwa, Taiwan
[7] Natl Chung Hsing Univ, Coll Life Sci, Taichung 40227, Taiwan
关键词
ZUSANLI ACUPOINTS; STIMULATION; SENSITIVITY;
D O I
10.1155/2011/947138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to explore the mechanisms by which electroacupuncture (EA) enhances the hypoglycemic effect of exogenous insulin in a streptozotocin- (STZ-) diabetic rats. Animals in the EA group were anesthetized and subjected to the insulin challenge test (ICT) and EA for 60 minutes. In the control group, rats were subjected to the same treatment with the exception of EA stimulation. Blood samples were drawn to measure changes in plasma glucose, free fatty acids (FFA), and insulin levels. Western blot was used to assay proteins involved in insulin signaling. Furthermore, atropine, hemicholinium-3 (HC-3), and Eserine were used to explore the relationship between EA and cholinergic nerve activation during ICT. EA augmented the blood glucose-lowering effects of EA by activating the cholinergic nerves in STZ rats that had been exposed to exogenous insulin. This phenomenon may be related to enhancement of insulin signaling rather than to changes in FFA concentration.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] SHILAJIT-INDUCED POTENTIATION OF THE HYPOGLYCEMIC ACTION OF INSULIN AND INHIBITION OF STREPTOZOTOCIN-INDUCED DIABETES IN RAT
    KANIKKANNAN, N
    RAMARAO, P
    GHOSAL, S
    PHYTOTHERAPY RESEARCH, 1995, 9 (07) : 478 - 481
  • [2] Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus
    Haughton, CL
    Dillehay, DL
    Phillips, LS
    LABORATORY ANIMAL SCIENCE, 1999, 49 (06): : 639 - 644
  • [3] The effect of electroacupuncture on bladder dysfunction caused by streptozotocin-induced diabetes
    Liao, Jiuan-Miaw
    Lin, Tzer-Bin
    Liou, Ying-Ming
    FASEB JOURNAL, 2010, 24
  • [4] EFFECT OF STREPTOZOTOCIN-INDUCED DIABETES ON PANCREATIC INSULIN CONTENT OF RAT FETUSES
    BECKER, KL
    RISHI, S
    PHARMACOLOGIST, 1970, 12 (02): : 228 - &
  • [5] STREPTOZOTOCIN-INDUCED DIABETES IN RAT
    DULIN, WE
    LUND, GH
    GERRITSE.GC
    DIABETES, 1967, 16 (07) : 512 - &
  • [6] Electroacupuncture at the Zusanli (ST-36) Acupoint Induces a Hypoglycemic Effect by Stimulating the Cholinergic Nerve in a Rat Model of Streptozotocine-Induced Insulin-Dependent Diabetes Mellitus
    Lee, Yu-Chen
    Li, Te-Mao
    Tzeng, Chung-Yuh
    Chen, Ying-I
    Ho, Wai-Jane
    Lin, Jaung-Geng
    Chang, Shih-Liang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 6
  • [7] THE EFFECT OF STREPTOZOTOCIN-INDUCED DIABETES ON CHOLINERGIC MOTOR TRANSMISSION IN THE RAT URINARY-BLADDER
    LUHESHI, GN
    ZAR, MA
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (03) : 1657 - 1662
  • [8] CHOLINERGIC AND GABAERGIC RECEPTOR FUNCTIONAL DEFICIT IN THE HIPPOCAMPUS OF INSULIN-INDUCED HYPOGLYCEMIC AND STREPTOZOTOCIN-INDUCED DIABETIC RATS
    Sherin, A.
    Anu, J.
    Peeyush, K. T.
    Smijin, S.
    Anitha, M.
    Roshni, B. T.
    Paulose, C. S.
    NEUROSCIENCE, 2012, 202 : 69 - 76
  • [9] Rat is a Suitable Animal Model for Streptozotocin-induced Diabetes
    Assavacheep, A.
    Tienthai, P.
    THAI JOURNAL OF VETERINARY MEDICINE, 2011, 41 (01): : S30 - S31
  • [10] Effect of streptozotocin-induced diabetes on rat brain mitochondria
    Moreira, PI
    Santos, MS
    Moreno, AM
    Proença, T
    Seiça, R
    Oliveira, CR
    JOURNAL OF NEUROENDOCRINOLOGY, 2004, 16 (01) : 32 - 38